Profit and Loss Acc

Glaxosmithkline Pharma Ltd

(Rs in Crs)
Year
INCOME :
Sales Turnover
Excise Duty
Net Sales
Other Income
Stock Adjustments
Total Income
EXPENDITURE :
Raw Materials
Power & Fuel Cost
Employee Cost
Other Manufacturing Expenses
Selling and Administration Expenses
Miscellaneous Expenses
Total Expenditure
Operating Profit
Interest
Gross Profit
Depreciation(Current Year)
Profit Before Tax
Tax
Fringe Benefit tax
Deferred Tax
Reported Net Profit
Extraordinary Items
Adjusted Net Profit
P & L Balance brought forward
Appropriations
P & L Balance carried down
Dividend
Equity Dividend %
Earnings Per Share-Unit Curr
Book Value-Unit Curr

Dec 13

Dec-12

Dec-11

Dec-10

Dec-09

2619.37
73.22
2546.15
229.31
50.75
2826.21

2696.48
70.04
2626.44
197.35
-52.59
2771.2

2429.58
53.7
2375.88
159.95
56.09
2591.92

2155.08
43.44
2111.64
147.73
20.19
2279.56

1912.77
40.12
1872.65
152.87
32.41
2057.93

1208.57
23.85
362.09
90.91
321.06
70.51
2077
749.2
0
749.2
19.88
729.32
233
0
-5.57
501.88
18.98
482.9
1142.95
544.9
1099.93
423.52
500
50.85
238.15

1045.26
22.5
393.57
64.57
286.05
94.84
1906.79
864.4
0
864.4
17.84
846.56
294.38
0
-25.07
577.26
-96.56
673.82
1110.59
544.9
1142.95
423.52
500
60.63
237.3

964.6
26.7
287.49
74.5
269.01
349.82
1972.12
619.8
0.33
619.47
20.41
599.06
180.68
-7.15
-5.07
430.6
-160.67
591.27
1164.53
484.54
1110.59
381.16
450
43.72
226.67

797.19
26.75
234.53
64.69
246.75
50.63
1420.54
859.02
0.62
858.4
17.63
840.77
288.78
0
-11.7
563.69
-17.04
580.73
1049.23
448.39
1164.53
338.81
400
60.27
227.96

724.63
24.66
203.98
59.67
219.69
35.3
1267.93
790
0.37
789.63
16.37
773.26
274.22
1.85
-15.1
512.29
9.78
502.51
882.41
345.47
1049.23
254.11
300
55.74
207.69

http://www.capitaline.com/user/framepage.asp?id=1

19.05 PM, 10th August

http://www.indiainfoline.com/Markets/Company/Fundamentals/Profit-Loss/Sanofi-India-Ltd/500674

http://www.indiainfoline.com/Markets/Company/Fundamentals/Profit-Loss/Glaxosmithkline-Pharma-Ltd/500660

nd Loss Account Details

Sanofi India Ltd
(Rs in Crs)
Year
INCOME :
Sales Turnover
Excise Duty
Net Sales
Other Income
Stock Adjustments
Total Income
EXPENDITURE :
Raw Materials
Power & Fuel Cost
Employee Cost
Other Manufacturing Expenses
Selling and Administration Expenses
Miscellaneous Expenses
Total Expenditure
Operating Profit
Interest
Gross Profit
Depreciation(Current Year)
Profit Before Tax
Tax
Fringe Benefit tax
Deferred Tax
Reported Net Profit
Extraordinary Items
Adjusted Net Profit
P & L Balance brought forward
Appropriations
P & L Balance carried down
Dividend
Equity Dividend %
Earnings Per Share-Unit Curr
Book Value-Unit Curr

Dec 13

Dec-12

Dec-11

Dec-10

Dec-09

1,854.85 1,612.82 1,330.20 1,107.26 995.79

45.99
39.78
28.86
22.31
21.38
1,808.86 1,573.04 1,301.34 1,084.95 974.41
83.24
41.17 155.61 267.42 167.35
9.47
8.93
10.12
12.03
23.46
1,901.57 1,623.14 1,467.07 1,364.40 1,165.22
828.9 744.42 626.93 551.02
41.83
34.15
27.08
21.08
242.13 213.78 176.42 161.25
51.26
49.43
45.81
46.9
306.76 280.89
235.2 214.16
-50.45
-52.51
40.08
37.62
1,420.43 1,270.16 1,151.52 1,032.03
481.14 352.98 315.55 332.37
0.42
1.4
0.42
2.89
480.72 351.58 315.13 329.48
92.26
89.87
31.15
19.74
388.46 261.71 283.98 309.74
107.87
72.23
74.32
74.27
0
0
0
0
15.41
12.82
18.48
4.72
265.18 176.66 191.18 230.75
25.22
-0.05
-0.01
75.53
239.96 176.71 191.19 155.22
913.32 842.65 758.45 698.34
148.28 105.99 106.98 170.64
1,030.22 913.32 842.65 758.45
103.64
76
76 126.67
450
330
330
550
107.28
71.36
77.86
91.12
580.3 518.02 479.67 434.81

505.42
19.5
141.03
39.71
180.61
20.07
906.34
258.88
0.07
258.81
17.34
241.47
81.24
2.07
0.74
157.42
-0.16
157.58
610.55
69.63
698.34
46.06
200
64.95
398.68

a-Ltd/500674

kline-Pharma-Ltd/500660

Balance Sh
Glaxosmithkline Pharma Ltd
(Rs in Crs)
Year
SOURCES OF FUNDS :
Share Capital
Reserves Total
Total Shareholders Funds
Secured Loans
Unsecured Loans (Deferred Tax)
Total Debt
Other Liabilities
Total Liabilities
APPLICATION OF FUNDS :
Gross Block
Less : Accumulated Depreciation
Net Block
Capital Work in Progress
Investments
Current Assets, Loans & Advances
Inventories
Sundry Debtors
Cash and Bank
Loans and Advances
Total Current Assets
Less : Current Liabilities and Provisions
Current Liabilities
Provisions
Total Current Liabilities
Net Current Assets
Deferred Tax Assets
Deferred Tax Liability
Net Deferred Tax
Other Assets
Total Assets
Contingent Liabilities

Dec 13

Dec 12

Dec 11

Dec 10

84.7
1,932.49
2,017.19
0
4.14
4.14
246.01
2,267.34

84.7
1,925.31
2,010.01
0
4.59
4.59
239.76
2,254.36

84.7
1,835.23
1,919.93
0
4.9
4.9
228.56
2,153.39

84.7
1,846.11
1,930.81
0
5.16
5.16
0
1,935.97

299.08
199.01
100.07
61.86
57.67

272.04
182.63
89.41
43.79
102.58

271.66
172.53
99.13
16.19
159.8

318.4
209.47
108.93
8.72
160.35

342.4
96.39
2,027.14
125.8
2,591.73

282.04
115.9
2,038.78
130.77
2,567.49

330.14
85.31
1,984.09
112.73
2,512.27

281.54
47.02
1,948.08
171.69
2,448.33

363.7
518.83
882.53
1,709.20
96.9
4.79
92.11
246.43
2,267.34
327.5

323.09
512.21
835.3
1,732.19
89.75
3.21
86.54
199.87
2,254.37
228.4

266.4
591.27
857.67
1,654.60
67.43
5.96
61.47
162.2
2,153.39
277.32

346.22
500.54
846.76
1,601.57
65.14
8.74
56.4
0
1,935.97
214.51

http://www.indiainfoline.com/Markets/Comp
any/Fundamentals/BalanceSheet/Glaxosmithkline-Pharma-Ltd/500660 10th August 2014, 20:41

http://www.indiainfoline.com/Markets/Comp
any/Fundamentals/Balance-Sheet/SanofiIndia-Ltd/500674
10th August 2014, 20:43

Current Ratio = (Current Assets)/(Current

Liabilities)
Dec 09
Dec 10
Dec 11
Dec 12
Dec 13

Glaxo

Sanofi
2.49
2.99
2.96
3.08
3.1

3.66
3.27
2.42
1.88
1.96

Industry
2.2
2.1
0.97
1.57
3.35

Balance Sheet Details

Sanofi India Ltd
(Rs in Crs)
Dec 09
84.7
1,674.45
1,759.15
0
5.42
5.42
0
1,764.57
289.18
196.37
92.81
21.36
190.91
253.02
53.73
1,672.60
135.07
2,114.42
316.66
382.96
699.62
1,414.80
52.28
7.59
44.69
0
1,764.57
204.66

Year
SOURCES OF FUNDS :
Share Capital
Reserves Total
Total Shareholders Funds
Secured Loans
Unsecured Loans
Total Debt
Other Liabilities
Total Liabilities
APPLICATION OF FUNDS :
Gross Block
Less : Accumulated Depreciation
Net Block
Capital Work in Progress
Investments
Current Assets, Loans & Advances
Inventories
Sundry Debtors
Cash and Bank
Loans and Advances
Total Current Assets
Less : Current Liabilities and Provisions
Current Liabilities
Provisions
Total Current Liabilities
Net Current Assets
Deferred Tax Assets
Deferred Tax Liability
Net Deferred Tax
Other Assets
Total Assets
Contingent Liabilities

Dec 13

Dec 12

Dec 11

Dec 10

23.03
23.03
23.03
23.03
1,323.67 1,181.09 1,093.59 991.12
1,346.70 1,204.12 1,116.62 1,014.15
0
0
0
0
0
0
0
0
0
0
0
0
26.02
19.28
20.56
0
1,372.72 1,223.40 1,137.18 1,014.15
1,102.18 1,014.38
403.63 315.02
698.55 699.36
136.2
43.47
0.24
0.36
340
118.31
264.4
224.43
947.14

272.45
98.9
430.2
27.1
828.65

967.92
230.95
736.97
22.86
0.36

375.5
204.45
171.05
13.3
0.36

254.27 238.47
104.09
60.44
234.23 655.35
74.15 259.59
666.74 1,213.85

277.03 238.16
218.54
173.7
158.35 148.47
138.36 220.56
435.38 386.63
356.9 394.26
511.76 442.02
309.84 819.59
28.47
26.19
22.81
25.32
65.16
47.47
31.27
15.47
-36.69
-21.28
-8.46
9.85
62.66
59.47
75.61
0
1,372.72 1,223.40 1,137.18 1,014.15
147.75 119.44
143.58 115.36

Dec 09
23.03
908.76
931.79
0
0
0
0
931.79
334.57
189.68
144.89
27.14
5.19
231.14
52.73
585.95
143.72
1,013.54
158.17
115.37
273.54
740
29.8
15.23
14.57
0
931.79
140.51

Net Profit Margin

Operating Ratio
Divident Payout Ratio(Equity)

Only 2

Liquidity Ratios
Current Ratio = (Current
Assets)/(Current Liabilities)

Glaxo
2.49
2.99
2.96
3.08

Dec 09
Dec 10
Dec 11
Dec 12
Dec 13
Inventory T.O = (Cost of
Goods Sold-COGS)/Inventory

Glaxo
7.95
8.06
7.94
8.81
8.39

Dec 09
Dec 10
Dec 11
Dec 12
Dec 13
Receivables or Debtors
Turnover
Dec 09
Dec 10
Dec 11
Dec 12
Dec 13

EPS
2010
2011
2012
2013

Sanofi
Industry
3.66
2.2
3.27
2.1
2.42
0.97
1.88
1.57
1.96
3.35

Sanofi
Industry
4.93
4.72
5.4
6.65
6.12
5.35
6.06
4.28

Glaxo
Sanofi
Industry
34.26
14
42.78
19.57
36.72
16.17
11.69
26.8
15.89
9.9
24.68
17.08
8.02

Glaxo
60.3
43.7
60.6
50.9

Sanofi
91.1
77.9
71.4
107.3

Total Income Glaxo

Sanofi
Dec 09(12)
2057.93 1,165.22
Dec 10(12)
2279.56 1,364.40
Dec 11(12)
2591.92 1,467.07
Dec 12(12)
2771.2 1,623.14
Dec 13(12)
2826.21 1,901.57

Total
Expenditure
Dec 09(12)
Dec 10(12)
Dec 11(12)
Dec 12(12)
Dec 13(12)

Industry
10,001.69
14,180.58
12,349.97
11,449.32
18,852.62

Glaxo
Sanofi
Industry
1267.93
906.34 8148.72
1,420.54 1,032.03 14,217.93
1,972.12 1,151.52 9,850.70
1,906.79 1,270.16 8,905.19
2,077.00 1,420.43 18,321.27

PBIDT
Dec 09(12)
Dec 10(12)
Dec 11(12)
Dec 12(12)
Dec 13(12)

Glaxo

PBDT
Dec 09(12)
Dec 10(12)
Dec 11(12)
Dec 12(12)
Dec 13(12)

Glaxo
Sanofi
Industry
789.63
258.81
1829.3
858.40
329.48
-60.33
619.47
315.13 2,476.55
864.40
351.58 2,543.31
749.20
480.72
506.62

790
859.02
619.80
864.40
749.20

Sanofi
Industry
258.88 1852.97
332.37
-37.34
315.55 2,499.25
352.98 2,544.13
481.14
531.34
PBT
Glaxo
Sanofi
Industry
Dec 09(12)
773.26
241.47
284.24
Dec 10(12)
840.77
309.74 2,368.76
Dec 11(12)
599.06
283.98 2,289.11
Dec 12(12)
846.56
261.71
-181.81
Dec 13(12)
729.32
388.46 1,748.98

PAT
Glaxo
Sanofi
Industry
Dec 09(12)
502.51
157.58 1111.04
Dec 10(12)
580.73
155.22
-594.97
Dec 11(12)
591.27
191.19 1,616.98
Dec 12(12)
673.82
176.71 1,269.61
Dec 13(12)
482.90
239.96
196.12

Company >> Finance >> Profit & Loss

Glaxosmithkline Pharma Ltd

Industry :Pharmaceuticals - Multinational

Break up of Appropriations
(Rs in Crs)
Year
Appropriation to Capital Redemption Reserve
Appropriation to Debenture Redemption Reserve
Appropriation to General Reserve
Appropriation to Investment Allowance Reserve
Appropriation to Other Reserves
Prior Year Dividend Paid
Provision for Equity Dividend
Provision for Preference Dividend
Dividend Tax
INTERIM DIVIDEND PAID

Dec
Dec
Dec
Dec
Dec
13(12) 12(12) 11(12) 10(12) 09(12)
0
0
0
0
0
0
0
0
0
0
50.19 57.73 43.06 56.37 51.23
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
423.5 423.5 381.2 338.8 254.1
0
0
0
0
0
71.19 63.66 60.32 53.21 40.13
0
0
0
0
0

Sanofi
India Ltd
Industry
:Pharmac
euticals Multinati
onal
Break up of Appropriations
(Rs in Crs)
Dec
Dec
Dec
Dec
Dec
Year
13(12)
12(12)
11(12)
10(12)
09(12)
0 Redemption
0
0
0
0
Appropriation to Capital
Reserve
0
0
0
0
0
Appropriation to Debenture
Redemption
Reserve
17.67
19.11
23.08
15.74
Appropriation to26.52
General Reserve
0
0
0
0
0
Appropriation to Investment
Allowance
Reserve
0 Reserves0
0
0
0
Appropriation to Other
0
0
0
0
0
Prior Year Dividend Paid
103.64
76
126.67
46.06
Provision for Equity
Dividend 76
0 Dividend
0
0
0
0
Provision for Preference
18.12
12.32
11.87
20.89
7.83
Dividend Tax
23.03
9.21
9.21
9.21
8.06
INTERIM DIVIDEND
PAID

Company >> Finance >> Profit & Loss

Glaxosmithkline Pharma Ltd

Sanofi
India Ltd

Industry :Pharmaceuticals Multinational

Break up of Tax
(Rs in Crs)

Industry
:Pharmac
euticals Multinati
onal
Break up of Tax
(Rs in Crs)

Year
Tax for the current year
Adjustment for Previous Year
Others

Dec
Dec
Dec
Dec
Dec
13(12) 12(12) 11(12) 10(12) 09(12)
233 294.4 300.65 289.5 274.4
0
0
0
0
0
0
0 -119.97 -0.74 -0.13

Year
Tax for the current year
Adjustment for Previous Y
Others

Break up of Tax
(Rs in Crs)
Dec
Dec
Dec
Dec
Dec
13(12)
12(12)
11(12)
10(12)
09(12)
107.87
72.23
74.32
80.85
82.7
0
0
0
-6.58
-1.46
0
0
0
0
0

Company >> Finance >> Profit & Loss

Glaxosmithkline Pharma Ltd

Industry :Pharmaceuticals Multinational

Break up of Selling and Administration Expenses
(Rs in Crs)
Dec
Dec
Dec
Dec
Dec
Year
13(12) 12(12) 11(12) 10(12) 09(12)
38.04 30.51 20.74 18.82 17.24
Rent,Rates and Taxes paid
0
0
0
0
0
Wealth Tax
0
0
0
0
0
Cess
38.04 30.51 20.74 18.82 17.24
Others
0
0
0
0
0
Sales Tax
0
0
0
0
0
Lease Rent / Hire Charges paid
4.43
3.19
3.15
2.93
2.35
Insurance
0
0
0
0
0
Discount paid
0
0 106.2 96.25 95.02
Advertisement
120.2 99.66
0
0
0
Marketing Expenses
0
0
0
0.05
0.03
Commssion expenses on sales
54.42 48.76 39.96 34.28 26.79
Distribution Expenses
0
0
0
0
0
Other Selling Expenses
0
0
0
0
0
Legal Expenses
12.96 15.36
0
0
0
Communication Expenses
58.05
56.82
48.87
40.13
34.91
Travel Expenses
1.26
0.95
0.93
0.94
0.94
Audit Expenses
0
0 13.55 12.58 10.71
Printing and Stationery
0
0
0
0
0
Royalty and technical fees
0
0
0
0
0
Other Fee Expenses
0.61
0.61
0.56
6.85
5.83
Director's Remuneration
11.67 12.09 11.27 10.25
9.27
Other Commission paid
0
0
3.83
4.43
4.67
R & D Expenses
19.44 18.11 19.97 19.24 11.93
Other Administrative Expenses

Sanofi
India Ltd
Industry
:Pharmac
euticals Multinati
onal
Break up of Selling and Administration Expenses
(Rs in Crs)
Dec
Dec
Dec
Dec
Dec
Year
13(12)
12(12)
11(12)
10(12)
09(12)
24.74paid 23.06
15.51
12.11
12.91
Rent,Rates and Taxes
0
0
0
0
0
Wealth Tax
0
0
0
0
0
Cess
24.74
23.06
15.51
12.11
12.91
Others
0
0
0
0
0
Sales Tax
0
0
0
0
Lease Rent / Hire Charges
paid 0
5.75
5.85
5.22
4.72
5.27
Insurance
0
0
0
0
0
Discount paid
92.93
80.02
72.31
57.82
Advertisement 94.57
0
0
0
0
Marketing Expenses 0
0
0
0
Commssion expenses0on sales 0
86.67
68.99
61.73
52.5
38.37
Distribution Expenses
0
0
0
0
0
Other Selling Expenses
9.97
10.96
14.38
8.73
Legal Expenses 9.74
0
0
0
0
0
Communication Expenses
60.33
58.42
49.54
44.94
39.92
Travel Expenses
0.62
0.54
0.47
0.45
Audit Expenses 0.66
0
0
0
0
0
Printing and Stationery
0
0
0
0
Royalty and technical0fees
0
0
0
0
Other Fee Expenses 0
0
0
0
2
2.92
Director's Remuneration
0
0
0
0
0
Other Commission paid
0
0
0
0
5.14
R & D Expenses
24.3Expenses
21.05
11.68
10.73
9.08
Other Administrative

Company >> Finance >> Profit & Loss

Glaxosmithkline Pharma Ltd

Industry :Pharmaceuticals - Multinational

Break up of Other Manufacturing Expenses
(Rs in Crs)
Year
Freight Inwards & Transport charges
Packing Materials
Job Work / Contract / Processing Charges
Drilling Operation Charges
Stores Consumed
Repairs
Repairs - Plant & machinery
Repairs - Building
Repairs - Others
Technical fees paid
Wheeling charges payable
Project / Production Charges
Own Film Production Expense
Handling, Clearing Charges
Coupon Sales, Food, Beverages
License Fee / Operation Charges
Other Operating Expenses

Dec
13(12)
0
0
0
0
4.16
13.03
9.61
3.3
0.12
0
0
0
0
0
0
0
73.73

Dec
12(12)
0
0
0
0
3.56
12.03
9.68
2.21
0.13
0
0
0
0
0
0
0
48.99

Dec
11(12)
0
0
0
0
3.15
13.45
10.58
2.74
0.13
0
0
0
0
0
0
0
57.9

Dec
10(12)
0
0
0
0
3.46
16.46
12.11
4.13
0.22
0
0
0
0
0
0
0
44.77

Dec
09(12)
0
0
0
0
4.02
14.71
11.08
3.33
0.3
0
0
0
0
0
0
0
40.94

Industry
:Pharmac
euticals Multinati
onal
Break up of Other Manufacturing Expenses
(Rs in Crs)
Dec
Dec
Dec
Dec
Dec
Year
13(12)
12(12)
11(12)
10(12)
09(12)
0
0
0
0
0
Freight Inwards & Transport
charges
0
0
0
0
Packing Materials 0
28.32
22.97
Job Work / Contract /0Processing0Charges 0
0
0
0
0
0
Drilling Operation Charges
2.7
2.33
3.21
2.52
Stores Consumed 2.78
17.82
14.39
12.84
10.15
9.19
Repairs
6.69
5.06
4.58
2.9
2.33
Repairs - Plant & machinery
0.92
1.1
1.35
1.39
Repairs - Building 0.73
8.41
7.16
5.9
5.47
Repairs - Others 10.4
0
0
0
0
Technical fees paid 0
0
0
0
0
0
Wheeling charges payable
0
0
0
0
0
Project / Production Charges
0
0
0
Own Film Production0Expense 0
0
0
0
0
0
Handling, Clearing Charges
0
0
2.55
0
0
Coupon Sales, Food, Beverages
0 Charges 0
0
0
0
License Fee / Operation
30.66
32.34
28.09
5.22
5.03
Other Operating Expenses

Company >> Finance >> Profit & Loss

Glaxosmithkline Pharma
Ltd

Industry :Pharmaceuticals Multinational

Break up of Employee Cost
(Rs in Crs)
Year
Salaries,Wages & Bonus
Contribution to funds
Staff Welfare Expenses
VRS compensation
Gratuity Paid
Other Employee Cost

Dec
13(12)
326.1
16.35
14.57
0.05
5.02
0

Dec
12(12)
262.9
14.18
14.09
98.06
4.35
0

Dec
Dec
Dec
11(12) 10(12) 09(12)
250.2 211.4 183.4
17.8 12.41 11.68
10.36 10.69
8.94
9.13
0
0
0
0
0
0
0
0

Sanofi
India Ltd
Industry
:Pharmac
euticals Multinati
onal
Break up of Employee Cost
(Rs in Crs)
Dec
Dec
Dec
Dec
Dec
Year
13(12)
12(12)
11(12)
10(12)
09(12)
155.34
140.58
122.5
Salaries,Wages 214.71
& Bonus 191.85
12.92
9.83
11.54
11.77
10.57
Contribution to funds
14.5
12.1
9.54
8.9
7.96
Staff Welfare Expenses
0
0
0
0
VRS compensation 0
0
0
0
0
0
Gratuity Paid
0
0
0
0
Other Employee Cost0

Company >> Finance >> Profit & Loss

Glaxosmithkline Pharma Ltd

Industry :Pharmaceuticals - Multinational

Break up of Raw Materials
(Rs in Crs)
Year
Opening Stock of Raw Materials
Purchases of Raw Material
Purchase of Trading Goods
Direct Expense on Purchase/Adjustment
Closing Stock of Raw Materials
Adjustment on amalgamation / trial runs

Dec
13(12)
0
538.57
670
0
0
0

Dec
12(12)
0
437.81
607.45
0
0
0

Dec
Dec
Dec
11(12)
10(12)
09(12)
62.31
54.92
62.35
425.96
427.21
389.23
533.37
377.37
327.97
0
0
0
57.04
62.31
54.92
0
0
0

Sanofi
India Ltd
Industry
:Pharmac
euticals Multinati
onal
Break up of Raw Materials
(Rs in Crs)
Dec
Dec
Dec
Dec
Dec
Year
13(12)
12(12)
11(12)
10(12)
09(12)
109.78
100.53
94.86
101.42
64.86
Opening Stock of
Raw Materials
696.21
497.22
439.88
420.08
Purchases of Raw
Material 568.36
190.77
135.38
104.58
120.89
Purchase of Trading
Goods185.31
0
0
0
0
0
Direct Expense on Purchase/Adjustment
109.78
100.53
94.86
101.42
Closing Stock of167.86
Raw Materials
0
0 runs 0
0
1.01
Adjustment on amalgamation
/ trial

2,669.97
Sales turnover2,593.39
/ Operating
Income 2,391.73
26.5
Other Operating 25.98
Divisions / Income

37.85

2,155.08

1,912.77

Company >> Finance >> Profit & Loss

Sanofi
India Ltd
Industry
:Pharmac
euticals Multinati
onal
Break up of Sales Turnover
(Rs in Crs)
Dec
Dec
Dec
Dec
Dec
Year
13(12)
12(12)
11(12)
10(12)
09(12)
1,533.63
995.79
Sales turnover1,752.45
/ Operating
Income 1,258.61 1,107.26
90.71
59.62
0
0
Job Work & Service
Income 69.96
0
0
0
0
0
Pool Account Adjustment
9.23
11.97
0
0
Other Operating 11.69
Divisions / Income
0
0
0
0
Discount Received 0

173.15

171.48

141.95

97.33

82.27

22.83
0.09

0.18
0

0
0

0.49
0.02

9.3
0

Rent received
Gain on Cancell. of Forward Contr/forex trans
Compensation / Reimbursement Income

0.65
0
0

0.66
0
0

0
0
0

0.64
1.43
0

0.57
0
1.25

Other commission Income

Provision Written Back
Miscellaneous Income

0
6.06
1.53

0
3.03
0

0
0
0

2.29
7.93
18.78

2.76
2.72
34.78

Interest Income
Profit on sale of Fixed Assets
Profit on sale of investments

Company >> Finance >> Profit & Loss

Sanofi
India Ltd
Industry
:Pharmac
euticals Multinati
onal
Break up of Other Income
(Rs in Crs)
Dec
Dec
Dec
Dec
Dec
Year
13(12)
12(12)
11(12)
10(12)
09(12)
0
0
7.52
7.97
Export Incentives 0
0
0
0
0
Import Entitlements 0
0.04
0.01
4.92
1.97
Dividend Income 0.02
28.45
53.87
34.08
31.08
Interest Income 32.89
0 Money 0
0
0
0
Interest on Applicaiton
0
0
0
0
Profit on sale of Fixed0Assets
0
0
0
75.74
0
Profit on sale of investments
0
0
0
0
Profit on buy-back of0share
0
0
0
Profit on buy-back of0debenture 0
0
0
0
0
0
Profit on premature redemption
10.26
10.33
10.88
12.25
Rent received 10.92
0
0
0
0
0
Lease Rent / Hire Charges
received
1.03
0
0
1
Gain on Cancell. of6.81
Forward Contr/forex
trans
0
0
0
0
0
Sale of Scrap
0
0
87.72
78.2
56.22
Compensation / Reimbursement Income
0
0
0
2.3
3.53
Refunds / Claims Received
0
0
0
0
0
Income from Subsidiaries
0
0
0
51.31
44.47
Fee Income
0 Commission
0
0
0
0
Income from Guarantee
0
0
0
0
0
Income from Underwriting
Commission
0
0
0
0
0
Other commission Income
0
0
0
Income from Leasing0Operations0
0
0
0
0
0
Income from Hire Purchase
Operations
0 Banking Operations
0
0
0
0
Income from Merchant
0
0
0
0
0
Income from Bill Discounting
0 Activities
0
0
0
0
Income from Investment
0
0
0
0
Income from Money 0Market Operations
0 transfer / 0sale of invest
0
0
0
Profit on inter scheme
0
0
0
0
0
Sale of Power
0
0
0
0
0
Wheeling Charges received
0.03
0.03
0
6.91
Provision Written 6.27
Back
26.33
1.36
3.65
2.47
1.95
Miscellaneous Income

Year

Dec
13(12)

Dec
12(12)

Dec
11(12)

Dec
10(12)

Dec
09(12)

Closing Stock Of WIP

Closing Stock of Finished Goods
Closing Stock of Other Materials

32.34
236.61
0

33.33
184.87
0

54.6
216.18
0

51.76
162.93
0

41.86
152.64
0

Opening Stock of WIP

Opening Stock of Finished Goods
Opening Stock of Other Materials
Adjustment on amalgamation / trial runs

33.33
184.87
0
0

54.6
216.18
0
0

51.76
162.93
0
0

41.86
152.64
0
0

36.9
125.19
0
0

Company >> Finance >> Profit & Loss

Sanofi
India Ltd

Industry
:Pharmac
euticals Multinati
onal
Break up of Stock Adjustments
(Rs in Crs)
Dec
Dec
Dec
Dec
Dec
Year
13(12)
12(12)
11(12)
10(12)
09(12)
29.08
27.92
23.65
21.34
Closing Stock Of 32.68
WIP
133.59
125.82
119.96
108.38
Closing Stock of139.46
Finished Goods
0
0
0
Closing Stock of Other0 Materials 0
27.92
23.65
21.34
28.21
Opening Stock of29.08
WIP
133.59
125.82
119.96
108.38
79.48
Opening Stock of
Finished Goods
0 Materials0
0
0
0
Opening Stock of Other
0
0 runs-0.01
-1.86
1.43
Adjustment on amalgamation
/ trial